Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 2/2014

01-02-2014 | Editorial

Letter regarding Li et al. entitled “Quantitative assessment of the association between CYP1A1 A4889G polymorphism and endometrial cancer risk”

Author: Rongji Zhang

Published in: Tumor Biology | Issue 2/2014

Login to get access

Excerpt

To the Editor, …
Literature
1.
Min L, Yuanyue L, Xiaoyan X, et al. Quantitative assessment of the association between CYP1A1 A4889G polymorphism and endometrial cancer risk. Tumor Biol. 2013. doi:10.​1007/​s13277-013-0949-y.
2.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.PubMedCentralPubMedCrossRef
Metadata
Title
Letter regarding Li et al. entitled “Quantitative assessment of the association between CYP1A1 A4889G polymorphism and endometrial cancer risk”
Author
Rongji Zhang
Publication date
01-02-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 2/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1251-8

Other articles of this Issue 2/2014

Tumor Biology 2/2014 Go to the issue

Research Article

Diagnostic relevance of plasma DNA and DNA integrity for breast cancer

Research Article

Association of COX2 gene hypomethylation with intestinal type gastric cancer in samples of patients from northern Brazil

Research Article

Antiapoptotic gene BAG-1 vector structure of RNA interference and endogenous targeted screening in colon cancer cell lines

Research Article

XRCC1 polymorphisms and cervical cancer risk: an updated meta-analysis

Research Article

Everolimus in combination with letrozole inhibit human breast cancer MCF-7/Aro stem cells via PI3K/mTOR pathway: an experimental study

Research Article

Smoking and hOGG1 Ser326Cys polymorphism contribute to lung cancer risk: evidence from a meta-analysis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits